InnoCare Pharma Ltd
HKEX:9969
InnoCare Pharma Ltd
HKEX:9969
Price:
5.12 HKD
Updated:
May 7, 2024
InnoCare Pharma Ltd
Cash from Investing Activities
|
InnoCare Pharma Ltd
Cash from Investing Activities Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
InnoCare Pharma Ltd
HKEX:9969
|
Cash from Investing Activities
-¥1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥2.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥993.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is InnoCare Pharma Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.8B
CNY
-1.8B
CNY
Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Cash from Investing Activities amounts to -1.8B CNY.
What is InnoCare Pharma Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
-5%
-5%
Over the last year, the Cash from Investing Activities growth was -5%.
You don't have any saved screeners yet
